Video

Dr. Unger on Utilizing a Multidisciplinary Team in Gastroesophageal Cancer

Keith R. Unger, MD, discusses utilizing a multidisciplinary team to treat patients with gastroesophageal cancer.

Keith R. Unger, MD, director, Gastrointestinal Cancer Service, Department of Radiation Medicine, director of the residency training program, MedStar Georgetown University Hospital, and associate professor of radiation medicine, Georgetown University School of Medicine, discusses utilizing a multidisciplinary team to treat patients with gastroesophageal cancer.

Tumor boards at MedStar Georgetown University Hospital consist of interventional gastroenterologists, surgeons, imaging specialists, pathologists, medical oncologists, and radiation oncologists.

Additionally, team members from supportive care including a nutritionist and social worker may be present to offer insight on other issues that can arise over the course of treatment, concludes Unger.

Related Videos
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Tiago Biachi, MD, PhD
Dr Girard on De Novo and Acquired Resistance Alterations in HER2-Altered NSCLC
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses how physician assistants aid in treatment planning for NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses DNA vs RNA sequencing for genetic testing in non–small cell lung cancer and pancreatic cancer.